R&D Partner Content 7th Annual AI in Drug Discovery Conference The 7th Annual AI in Drug Discovery Conference, hosted by SAE Media Group, takes place in March 2026
R&D Partner Content Novo Nordisk seeks to target heart disease with Cardior acqu... Cardior CSO will speak at the Oligonucleotide Therapeutics and Delivery conference following announcement of a buyout by Novo Nordisk to enhance their
R&D Partner Content Pre-Filled Syringes Connect SAE Media Group are proud to announce the inaugural Pre-Filled Syringes Connect event taking place on the 11th and 12th of September in Boston.
R&D Partner Content Wearable Injectors and Connected Devices UK SAE Media Group’s 5th Annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and d
R&D Partner Content The Wearable Injectors and Connected Devices USA conference The Wearable Injectors and Connected Devices event is the only conference that discusses both wearable injectors and connected devices in one event.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.